Keywords

• 459789-99-2
• 6-Ethylchenodeoxycholic acid
• Obeticholic Acid

Quick Details

• ProName: Top Quality Powder 6-Ethylchenodeoxych...
• CasNo: 459789-99-2
• Molecular Formula: SHMP
• Appearance: White powder
• Application: 459789-99-2
• DeliveryTime: within 1-3 days
• PackAge: carton box
• Port: tianjin/shanghai/qingdao
• ProductionCapacity: 1000000 Kilogram/Month
• Purity: 99%
• Storage: cool and dry
• Transportation: by air by sea or by express
• LimitNum: 1 Kilogram
• Moisture Content: <0.1%
• Impurity: <0.1%
• Appearance: white powder
• Content: 99.0-100.5%
• loss on drying: <0.5%
• Melting point: 202℃-210℃

Superiority

Product quality:

Our company have high quality product , and also  the product we have good manufacture .

First of all, this product is of fine quality. Every finish should be checked by quality inspection system.And every one should be also tried out for one month.Besides，this type has a good viscosity. the prouct can make Gel hand sanitizer thickener cosmetics industry.

We can ensure the product quality , If the product is not satisfactory, you can return it at any time.

Manufacturing technique

In the chemical industry, the process of producing a chemical product. Including raw material pretreatment, reactant chemical reaction and chemical product separation purification, final packaging sales.

Price

our product have resonable price and good service high quality and inexpensive, you deserve.every webiste we have the sales point, your purchase is convenient.

Service

Any time on line , from 0.00-24:00 . if you have any questions , pls contact with me ,As long as you have the need, we will serve you wholeheartedly

Details

Product information

Product Name 6-Ethylchenodeoxycholic acid
Appearance White to off-white powder
CAS 459789-99-2
Other Name Obeticholic Acid
Grade Medicine & Tech
Assay 99%min
Shelf life 2 Years
Color White to off-white
Standard NLT 98%
Application Pharm Intermediates

Oberbic acid is developed by the US Intercept Pharmaceutical Company, and it is the first drug in 20 years developed for the treatment of cholestatic liver disease.The study was applied to patients who did not adequately respond to or cannot tolerant the old standard treatment--ursodeoxycholic acid. In a phase III, placebo-controlled trial, oberbetate (OCA) increased the levels of two biomarkers associated with a reduced risk of liver transplantation. The composite endpoint of clinical studies is a decrease at least 15% in alkaline phosphatase activity and of a serum albuminase activity which is 1.67-fold lower than the normal upper limit, whereas in the normal range of bilirubin, alkaline phosphatase is a biomarker used to indicate the severity of liver disease.

Certification of analysis

Function 

1.Can increase the secretion of bile acid;
2.Reduce cholesterol in bile and cholesterol ester;
3.Is conducive to the cholesterol gradually dissolve gallstones;

4.Should not be used for surgical treatment of cholesterol stone, but cannot dissolve the bile pigment stone, mixing and opaque X line of stones.

Company Information

Hebei Mojin Biotechnology Co., Ltd, Our company is a professional in lead acetate, diphenyl ethylamine and other chemical raw materials and chemical reagents research and development production enterprises. Our business covers more than 30 countries, most of the big customers come from Europe, America and other countries in the world, we can guarantee the quality and price. In recent decades, with the efforts of all employees, we have established many cooperative companies in shandong, henan, guangdong and other places. Our corporate purpose is based on the market, enhance the strength, take the road of scientific and environmental sustainable development, relying on the country. Technology r & d center, increase the investment in r & d, based on the domestic market, expand the international market, manufacturing quality products, sincere service to the society, into a modern, ecological, scientific and technological enterprise world.